|
MYADM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.400000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.172600E-01 |
| Normal-vs-Stage2 |
1.581940E-02 |
| Normal-vs-Stage3 |
1.313240E-01 |
| Normal-vs-Stage4 |
3.753400E-01 |
| Stage1-vs-Stage2 |
2.198100E-02 |
| Stage1-vs-Stage3 |
3.616200E-01 |
| Stage1-vs-Stage4 |
7.629400E-01 |
| Stage2-vs-Stage3 |
2.776600E-01 |
| Stage2-vs-Stage4 |
4.128000E-01 |
| Stage3-vs-Stage4 |
8.912400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.767000E-01 |
| Normal-vs-AfricanAmerican |
3.658400E-01 |
| Normal-vs-Asian |
3.322000E-03 |
| Caucasian-vs-AfricanAmerican |
9.531200E-01 |
| Caucasian-vs-Asian |
8.003000E-03 |
| AfricanAmerican-vs-Asian |
1.374150E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.363600E-01 |
| Normal-vs-Female |
3.455200E-01 |
| Male-vs-Female |
7.292600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.096190E-01 |
| Normal-vs-Extreme_Weight |
5.380800E-01 |
| Normal-vs-Obese |
7.348600E-01 |
| Normal-vs-Extreme_Obese |
1.236180E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.163200E-01 |
| Normal_Weight-vs-Obese |
1.444220E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.497780E-02 |
| Extreme_Weight-vs-Obese |
6.876000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.560740E-03 |
| Obese-vs-Extreme_Obese |
3.969100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.288000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.089800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.463900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.962600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.637200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.092800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.561800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.475010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.607600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.910400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.593200E-01 |
| Normal-VS-Type2 PRCC |
2.810200E-02 |
| Normal-VS-KIRP CIMP |
7.290200E-01 |
| Normal-VS-Unclassified PRCC |
1.926010E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.756300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.427400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.047400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.062000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.040200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.595200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.012420E-02 |
| Normal-vs-N1 |
3.856600E-01 |
| Normal-vs-N2 |
8.270000E-01 |
| N0-vs-N1 |
1.119630E-01 |
| N0-vs-N2 |
2.544000E-02 |
| N1-vs-N2 |
4.432400E-01 |
|
|
